Selling Korean-Made Cosmetics in the US: MoCRA Requirements for Your Brand

For many brands built on Korean-made skincare, the United States is a key market to plan for. In 2025 export statistics released by Korea’s Ministry of Food and Drug Safety (MFDS) in May 2026, the US overtook China as the largest destination for Korean cosmetics, at about US$2.2 billion. Selling there means meeting MoCRA requirements: the obligations added by the Modernization of Cosmetics Regulation Act of 2022.

MoCRA does not create an FDA approval process for cosmetics. Instead, it splits duties between the facility that makes the product and the company named on the label. Knowing which side you are on saves time before your first US shipment.

This guide summarizes the FDA pages cited. It is not legal advice: confirm current requirements with FDA or a regulatory consultant before you launch.

MoCRA Requirements at a Glance

According to FDA’s MoCRA overview (content current as of August 2026) and its registration and listing page, the main obligations are:

• Facility registration: manufacturers and processors register their facilities with FDA and renew every two years.
• Product listing: each marketed cosmetic is listed with its ingredients and updated annually.
• Adverse-event reporting: serious adverse events must be reported to FDA within 15 business days.
• Safety substantiation: records supporting each product’s safety must be kept.
• Recalls and records access: FDA can order a mandatory recall if the responsible person refuses a voluntary one, and can access certain records, including safety records, if certain conditions are met.

Manufacturer vs. Responsible Person: Who Does What

The manufacturing facility registers itself with FDA. Foreign facilities that make or process cosmetics for US distribution must also name a US agent.

The responsible person is the manufacturer, packer or distributor whose name appears on the label. For a private-label brand, that is usually the brand or its US distributor, depending on whose name is on the label. The responsible person lists each product with its ingredients, updates the listing annually, reports serious adverse events and keeps safety-substantiation records.

For example: a US brand sells a Korean-made serum under its own name. The Korean factory registers its facility; the brand handles the product listing, adverse-event reports and safety records.

Note that FDA does not issue certificates or other documents to verify registration or listing. If anyone offers you an “FDA certificate” for a cosmetic, ask exactly what it is. And because facility and product sit in separate filings, agree early with your manufacturer what information it will share for your listing.

Cosmetic or Drug? The Claims That Change Everything

In the US, a product’s intended use decides whether it is a cosmetic, a drug or both. FDA’s examples of claims that make a product a drug include restoring hair growth, affecting melanin production and regenerating cells. Common traps include:

• Sun protection: a moisturizer with sun-protection claims is both a cosmetic and a drug.
• Anti-dandruff: anti-dandruff shampoos are cosmetic–drug combinations.
• Acne treatment: acne medications are a nonprescription drug category, so a product intended to treat acne is regulated as a drug.
• Hair growth: claims to restore hair growth are drug claims.

This matters at the border. According to an analysis by the regulatory news service ChemLinked, FDA refused about 1,300 batches of imported cosmetics in 2024, and 723 involved products marketed with therapeutic claims, making them unapproved drugs. South Korea was among the leading origin countries for refusals.

A claim that is acceptable in Korea may still make a product a drug in the US. FDA can judge intended use from labeling, advertising and online promotion, so review your label, website and marketplace copy together. If a regulated claim is essential, plan its testing and drug requirements before production.

US Labeling Basics

FDA’s Cosmetics Labeling Guide sets out the core elements. For an imported cosmetic, check that your label includes:

• Identity and net quantity on the principal display panel
• Name and place of business of the manufacturer, packer or distributor
• Ingredients in descending order of predominance
• Any required warnings
• All required statements in English
• The country of origin, written in English

Colors need separate attention. Color additives must be FDA-approved for their intended use, and FDA notes that color additive violations are a common reason imported cosmetics are detained. Check every colorant against US rules, not only Korean ones, and plan label text early in your packaging design, since small tubes and jars leave little space.

What Is Still Pending

As of FDA’s MoCRA page (content current as of August 2026):

• Good manufacturing practice (GMP): MoCRA requires FDA to establish GMP regulations for cosmetic manufacturing facilities; no final rule was listed.
• Fragrance allergens: MoCRA requires FDA to establish fragrance allergen labeling regulations; no final rule was listed either.
• Talc testing: a proposed rule was issued in December 2024 and withdrawn in November 2025.

Check FDA’s page for the current status before each launch, since any of these could change your obligations.

The Small-Business Exemption and Its Limits

FDA explains that MoCRA exempts certain small businesses from GMP, registration and product listing requirements. The exemption does not apply to products that:

• Come into contact with the mucous membrane of the eye
• Are injected
• Are intended for internal use
• Are intended to alter appearance for more than 24 hours under normal use, without removal by the consumer

FDA describes the exemption for GMP, registration and listing only, so adverse-event reporting and safety substantiation still need a plan. Ask a regulatory consultant whether your business qualifies.

Frequently Asked Questions

Do I need FDA approval to sell skincare in the US?

Generally, no. FDA states that the law does not require cosmetic products and ingredients, other than color additives, to have FDA approval before they go on the market. Companies that make or market cosmetics remain legally responsible for their safety, and products that are drugs, such as sunscreens, must meet drug requirements.

Can my Korean manufacturer list my products for me?

Listing is the responsible person’s duty, usually your brand or US distributor. Ask your manufacturer which ingredient lists and other export documentation it can provide for your file. Confirm with a regulatory consultant how, and by whom, your listing will be submitted.

Is a Korean SPF cream a cosmetic in the US?

Not only. US sunscreens are regulated as over-the-counter drugs, so a Korean SPF cream must meet US sunscreen drug requirements, including which UV filters may be used. Confirm the details with FDA or a regulatory consultant.

What is a US agent?

A US agent helps FDA communicate with a foreign facility, including about its products and inspections. Under FDA’s guidance on registration and listing, a foreign facility provides its US agent’s contact details when it registers. It is a facility-side role, separate from the responsible person on your label.

Final Thoughts

MoCRA rewards brands that plan the US file before production. Settle three questions early: who is the responsible person on your label, whether your claims keep the product a cosmetic, and whether your label and colorants meet US rules.

An experienced OEM/ODM partner makes that coordination easier, but the rules are still evolving. Treat this guide as a starting point and confirm current requirements with FDA or a consultant.